Strides Arcolab is currently trading at Rs. 901.00, up by 0.45 points or 0.05% from its previous closing of Rs. 900.55 on the BSE.
The scrip opened at Rs. 900.00 and has touched a high and low of Rs. 913.00 and Rs. 893.00 respectively. So far 58276 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1224.90 on 05-Dec-2012 and a 52 week low of Rs. 546.70 on 16-Mar-2012.
Last one week high and low of the scrip stood at Rs. 923.00 and Rs. 882.00 respectively. The current market cap of the company is Rs. 5318.23 crore.
The promoters holding in the company stood at 27.51% while Institutions and Non-Institutions held 49.31% and 23.18% respectively. Morgan Stanley Mauritius Company has sold 364,047 shares of Strides Arcolab in an open market transaction. The foreign fund house has sold the shares on Bombay Stock Exchange (BSE) at Rs 900.01 per share on March 12, 2013.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1910.50 |
Dr. Reddys Lab | 6635.50 |
Cipla | 1622.85 |
Lupin | 2197.60 |
Zydus Lifesciences | 1057.35 |
View more.. |